Anaprazole: Difference between revisions

Anaprazole
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Latest revision as of 16:45, 5 March 2025

A proton pump inhibitor used in the treatment of gastric acid-related disorders

Anaprazole is a proton pump inhibitor (PPI) that is used in the treatment of various conditions related to excessive gastric acid production. It is part of a class of medications that reduce stomach acid by blocking the enzyme in the wall of the stomach that produces acid.

Mechanism of Action[edit]

Anaprazole works by inhibiting the H+/K+ ATPase enzyme system, also known as the proton pump, in the gastric parietal cells. This action effectively reduces the production of gastric acid, providing relief from acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome.

Pharmacokinetics[edit]

Anaprazole is absorbed in the small intestine and undergoes hepatic metabolism. It is primarily metabolized by the cytochrome P450 enzyme system, particularly CYP2C19 and CYP3A4. The drug is then excreted through the urine and feces.

Clinical Uses[edit]

Anaprazole is indicated for the treatment of:

Side Effects[edit]

Common side effects of Anaprazole include headache, nausea, diarrhea, abdominal pain, and dizziness. Long-term use of PPIs, including Anaprazole, may be associated with an increased risk of osteoporosis-related fractures, Clostridium difficile infection, and hypomagnesemia.

Drug Interactions[edit]

Anaprazole may interact with other medications metabolized by the cytochrome P450 system. It can affect the absorption of drugs that require an acidic environment for optimal absorption, such as ketoconazole and iron supplements.

Related pages[edit]

@@ Line 1: / Line 1: @@
-{{Short description|An overview of the proton pump inhibitor Anaprazole}}
+{{Short description|A proton pump inhibitor used in the treatment of gastric acid-related disorders}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Anaprazole.svg
+| image2 =
+| width =
+| alt =
+| caption = Chemical structure of Anaprazole
+}}
-'''Anaprazole''' is a [[proton pump inhibitor]] (PPI) used in the treatment of various conditions related to excessive [[stomach acid]] production. It is primarily indicated for the management of [[gastroesophageal reflux disease]] (GERD), [[peptic ulcer disease]], and [[Zollinger-Ellison syndrome]].
+'''Anaprazole''' is a [[proton pump inhibitor]] (PPI) that is used in the treatment of various conditions related to excessive [[gastric acid]] production. It is part of a class of medications that reduce stomach acid by blocking the enzyme in the wall of the stomach that produces acid.
 ==Mechanism of Action==
-Anaprazole functions by irreversibly inhibiting the [[H+/K+ ATPase]] enzyme system, commonly known as the gastric proton pump, located in the [[parietal cells]] of the stomach lining. This inhibition prevents the final step in the production of gastric acid, thereby reducing acid secretion.
+Anaprazole works by inhibiting the [[H+/K+ ATPase]] enzyme system, also known as the proton pump, in the gastric parietal cells. This action effectively reduces the production of gastric acid, providing relief from acid-related conditions such as [[gastroesophageal reflux disease]] (GERD), [[peptic ulcer disease]], and [[Zollinger-Ellison syndrome]].
 ==Pharmacokinetics==
-Anaprazole is administered orally and is absorbed in the small intestine. It is a prodrug that requires activation in the acidic environment of the parietal cells. Once activated, it binds covalently to the proton pump, leading to a prolonged duration of action despite its relatively short plasma half-life.
+Anaprazole is absorbed in the small intestine and undergoes hepatic metabolism. It is primarily metabolized by the [[cytochrome P450]] enzyme system, particularly CYP2C19 and CYP3A4. The drug is then excreted through the urine and feces.
 ==Clinical Uses==
-Anaprazole is used in the treatment of:
+Anaprazole is indicated for the treatment of:
 * [[Gastroesophageal reflux disease]] (GERD)
 * [[Peptic ulcer disease]]
@@ Line 18: / Line 26: @@
 ==Side Effects==
-Common side effects of Anaprazole include:
+Common side effects of Anaprazole include headache, nausea, diarrhea, abdominal pain, and dizziness. Long-term use of PPIs, including Anaprazole, may be associated with an increased risk of [[osteoporosis]]-related fractures, [[Clostridium difficile]] infection, and [[hypomagnesemia]].
-* [[Headache]]
-* [[Nausea]]
-* [[Diarrhea]]
-* [[Abdominal pain]]
-Long-term use of PPIs like Anaprazole may be associated with an increased risk of [[bone fractures]], [[kidney disease]], and [[vitamin B12 deficiency]].
 ==Drug Interactions==
-Anaprazole may interact with other medications metabolized by the [[cytochrome P450]] system, particularly [[CYP2C19]]. It can affect the absorption of drugs that require an acidic environment, such as [[ketoconazole]] and [[iron supplements]].
+Anaprazole may interact with other medications metabolized by the cytochrome P450 system. It can affect the absorption of drugs that require an acidic environment for optimal absorption, such as [[ketoconazole]] and [[iron]] supplements.
-==Chemical Structure==
-[[File:Anaprazole.svg|Chemical structure of Anaprazole|thumb|right]]
-Anaprazole belongs to the benzimidazole class of compounds and shares structural similarities with other PPIs.
-==Related Pages==
+==Related pages==
 * [[Proton pump inhibitor]]
 * [[Gastroesophageal reflux disease]]